Early High-Dose Vitamin D3 for Critically Ill, Vitamin D–Deficient Patients | NEJM
Original Article from The New England Journal of Medicine — Early High-Dose Vitamin D3 for Critically Ill, Vitamin D–Deficient Patients
Related Articles
Marburg Virus Disease in Rwanda — Centering Both Evidence and Equity | NEJM
A unified response to the global threat posed by a Marburg virus disease outbreak in Rwanda offers reason for hope — and lessons about safeguarding…
Targeting a Hormonal Cause of Hypertension | NEJM
This interactive feature describes a woman who received a diagnosis of hypertension and preeclampsia at 27 years of age. After giving birth, her blood pressure…
Perioperative Chemotherapy or Preoperative Chemoradiotherapy in Esophageal Cancer | NEJM
The best multimodal approach for resectable locally advanced esophageal adenocarcinoma is unclear. An important question is whether perioperative chemotherapy is preferable to preoperative chemorad…
Perioperative Chemotherapy or Preoperative Chemoradiotherapy in Esophageal Cancer | NEJM
The best multimodal approach for resectable locally advanced esophageal adenocarcinoma is unclear. An important question is whether perioperative chemotherapy is preferable to preoperative chemorad…
Perioperative Chemotherapy or Preoperative Chemoradiotherapy in Esophageal Cancer | NEJM
The best multimodal approach for resectable locally advanced esophageal adenocarcinoma is unclear. An important question is whether perioperative chemotherapy is preferable to preoperative chemorad…
Obecabtagene Autoleucel in Adults with B-Cell Acute Lymphoblastic Leukemia | NEJM
Obecabtagene autoleucel (obe-cel) is an autologous 41BB-ζ anti-CD19 chimeric antigen receptor (CAR) T-cell therapy which uses an intermediate-affinity CAR to reduce toxic effects and improve…
Uncoupling Thrombosis and Hemostasis by Inhibiting Factor XI | NEJM
This editorial describes the science behind a clinical trial reported by Ruff et al. in which a monoclonal antibody targeting factors XI and XIa was…
Perioperative Chemotherapy or Preoperative Chemoradiotherapy in Esophageal Cancer | NEJM
The best multimodal approach for resectable locally advanced esophageal adenocarcinoma is unclear. An important question is whether perioperative chemotherapy is preferable to preoperative chemorad…
Perioperative Chemotherapy or Preoperative Chemoradiotherapy in Esophageal Cancer | NEJM
The best multimodal approach for resectable locally advanced esophageal adenocarcinoma is unclear. An important question is whether perioperative chemotherapy is preferable to preoperative chemorad…
Platelet-Targeted Gene Therapy for Hemophilia A with Inhibitor History | NEJM
Factor VIII gene was introduced into hematopoietic stem cells in men with hemophilia. The annualized bleeding rate went from 10 to 0. No worrisome gene…